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Abstract  
AIM: To determine the prognostic value of the low Pregnancy-associated plasma protein A (PAPP-
A) levels in the early stages of pregnancy (11–13 weeks GA) independently and in combination with 
a Doppler test of the uterine arteries during the second half of pregnancy (22–23 weeks GA). 
MATERIAL AND METHODS: The study covered the period 2010–2011 and included 106 pregnant 
women, aged 35–40, with a single child pregnancy. The research excluded pregnant women with 
anomalies of the fetus, smokers and women taking prophylactically low doses of aspirin. 
RESULTS: Thirty-six pregnant women had PAPP-A level below 0.4 MoM, whereas 20 of them 
developed preeclampsia and 7 – early preeclampsia. The combination of the low PAPP-A values 
and the abnormal Doppler test of the uterine arteries is with a considerably better prognostic value 
in regards to the risk of developing preeclampsia. 
CONCLUSION: The Doppler test is a non-invasive, quick and easy method for assessment of the 
uterine-placental blood flow. 
 
 
 
 
 
 
Introduction 
 
Preeclampsia (PE) is one of the most serious 
complications during the second half of pregnancy [1]. 
The high perinatal maternal mortality and the 
children’s pathology make it a priority in the research 
of a number of scientists and researchers [2].  
Our main goal was on the grounds of 
separate factors or a group of factors to determine 
who of the pregnant women display a high risk of 
developing preeclampsia with a view to the 
subsequent antenatal cares for them. In addition, we 
aimed to select markers that are comparatively easy, 
accessible and cost-effective for us and for our 
patients.  
 
Our task was to determine the prognostic 
value of the low PAPP – A levels in the early stages of 
pregnancy (11 – 13 weeks GA) independently and in 
combination with a Doppler test of the uterine arteries 
during the second half of pregnancy (22 – 23 weeks 
GA). 
 
 
Material and Methods 
 
The study covered the period 2010 – 2011 
and included 106 pregnant women, aged 35 – 40, with 
a single child pregnancy. The research excluded 
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pregnant women with anomalies of the fetus, smokers 
and women taking prophylactically low doses of 
aspirin. 
Out of all pregnant women observed, 26 
developed preeclampsia and 7 of them – early 
preeclampsia (before 34 weeks GA). In the beginning 
of the pregnancy, 27 of them were registered for 
increased Body Mass Index (BMI – 26 kg/m
2
). 
Thirteen out of all 26 women with preeclampsia had it 
during their previous pregnancies as well (Table 1).  
Table 1: Investigated parameters in the control group and in 
the patients with early preeclampsia and preeclampsia 
 Preeclampsia 
Early 
preeclampsia 
before 34 week 
GA 
Control 
group 
Combination of increased PI, RI, 
presence of incisures and reduced 
PAPP – A 
26 / 28% 7 / 7% 33 / 35% 
Presence of incisures in the early 
diastolic phase 
22 / 23% 6 / 6% 30 / 32% 
Increased PI values 19 / 20% 6 / 6% 38 / 40% 
Increased RI values 17 / 18% 5 / 5% 31 / 33% 
Reduced levels of PAPP – A 14 / 15% 2 / 2% 36 / 38% 
Anamnesis of previous preeclampsia 13 / 14% 4 / 4% 19 / 20% 
Miscarriages in the anamnesis 5 / 5% 2 / 2% 29 / 31% 
Increased BMI 12 / 13% 4 / 4% 27 / 29% 
Increased RR values before 
pregnancy 
27 / 29% 2 / 2% 32 / 34% 
Accompanying diseases 6 / 6% 1 / 1% 22 / 23% 
 
To examine the blood flow in the uterine 
arteries, MEDISON – AQUVIX V 10 and SONOACE X 
8 devices were used. The blood flow velocity was 
registered by means of 3.5 or 5 MHz transabdominal 
sector array transducers. The test was performed in a 
standard manner, the patient lying down on her back, 
and a colour Doppler was used to chartering the 
uterine artery while a pulsating Power Doppler and a 
transducer, parallel to the uterine artery (from 15
о
 – to 
30
о
) were employed to determine pulsatility index (PI) 
and resistive index (RI). 
The vascular resistance changes in the 
course of pregnancy. With its advance, the curves 
usually become low resistant – with low PI and RI and 
without diastolic incisures. The waveform was 
considered abnormal if there were bilateral notches 
with a mean RI of > 0.55, if there was a unilateral 
notch and a mean PI of > 0.65, or if the mean RI was 
0.70.  
  
 
 
Figure 1: A) Normal blood flow; B) Abnormal blood flow 
 
The quantitative measurement data of 
Pregnancy-associated plasma protein A (PAPP-A) 
were taken by the biochemical screening performed to 
these pregnant women at 11-13 week GA, employing 
the Delfia system for their laboratory determination. 
The low PAPP-A levels in the first trimester of 
pregnant women without chromosome anomalies are 
connected with an unfavourable perinatal outcome – 
intrauterine growth retardation (IUGR), preeclampsia, 
miscarries. These namely were the pregnant women 
subject mandatory to a Doppler test of their umbilical 
artery. On the grounds of this survey, we drew the 
conclusion that women with increased PI of the 
umbilical artery develop more frequently IUGR. In the 
control group of 33 women with reduced PAPP-A, 16 
pregnant women had IUGR. 
The Doppler test of the two uterine arteries 
was also performed to all pregnant women in the 
control group. 
 
 
Results 
 
The frequency of developing preeclampsia 
increases with the age of the mother with 35% which 
is above the average generally mentioned 
percentage. 
To determine the prognostic value of PAPP-A 
in the first trimester, the following data have been 
collected: 36 pregnant women had PAPP-A level 
below 0.4 MoM, whereas 20 of them developed 
preeclampsia and 7 – early preeclampsia. 
The combination of the low PAPP-A values 
and the abnormal Doppler test of the uterine arteries 
is with a considerably better prognostic value in 
regards to the risk of developing preeclampsia (Fig. 
1). 
 
Figure 1: The combination of the low PAPP-A values and the 
abnormal Doppler test of the uterine arteries 
 
 
Discussion 
 
The increased PI in both uterine arteries is a 
good and reliable prognostic indicator for 
preeclampsia. Besides, RI in one or in both arteries 
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also plays a role [3]. Especially sensitive turned out 
the factor with which we observed subjectively the 
presence of incisures in the early diastolic phase. 
Low serum PAPP-A levels are associated 
with a higher incidence of PE. Increased maternal 
serum PAPP-A levels have been observed in 
established PE [4-6]. A multicenter study of 8839 
women demonstrated a significant relationship 
between PAPP-A levels at or below the 5th percentile 
and IUGR preterm delivery, PE, and stillbirth [7]. 
Alteration in plasma levels of angiogenic 
factors is more pronounced in early preeclampsia 
during clinical disease compared to late-onset 
preeclampsia [8-11]. Wikström et al. demonstrate 43 
times higher median plasma concentrations of sFlt-1 
in early onset compared to a 3-fold increase in late-
onset preeclampsia and 21 times lower median 
plasma concentrations of PlGF in early onset disease 
compared to a 5-fold decrease in late-onset disease 
[8]. 
Although there are multiple potential 
biomarkers for PE their efficacy has been inconsistent 
and comparisons are difficult because of 
heterogeneity between different studies. Two papers 
with meta-analysis on biomarkers in preeclampsia 
were published recently (2015). Wu et al. found low 
predictive values using individual biomarkers which 
included a disintegrin and metalloprotease 12 (ADAM-
12), inhibin-A, pregnancy-associated plasma protein A 
(PAPP-A), placental growth factor (PlGF) and 
placental protein 13 (PP-13) [12]. In the second meta-
analysis the objective was to investigate the accuracy 
of serum biochemical markers(Pregnancy- Associated 
Plasma Protein-A (PAPP-A), human Chorionic 
Gonadotropin (hCG), Placental Growth Factor (PlGF), 
Placental Protein 13 (PP13) used in first trimester 
serum screening in predicting preeclampsia, small for 
gestational age (SGA) and preterm delivery [13]. The 
results showed low predictive accuracy overall. For 
preeclampsia, the best predictor was PlGF. The 
predictive value of serum markers for early 
preeclampsia was better than that of late 
preeclampsia. For SGA the best predictor was PP13. 
For preterm delivery, the best predictor was PP13 
[13]. 
The predictive value of all these factors, when 
combined, is significantly enhanced. 
In conclusion, the Doppler test is a non-
invasive, quick and easy method for assessment of 
the uterine-placental blood flow. 
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